MARTINI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.863
NA - Nord America 1.006
AS - Asia 997
SA - Sud America 213
AF - Africa 27
OC - Oceania 5
Totale 4.111
Nazione #
IT - Italia 1.266
US - Stati Uniti d'America 955
SG - Singapore 328
CN - Cina 282
BR - Brasile 179
SE - Svezia 148
HK - Hong Kong 132
NL - Olanda 111
JP - Giappone 106
DE - Germania 69
RU - Federazione Russa 45
VN - Vietnam 43
IN - India 42
FI - Finlandia 37
GB - Regno Unito 36
CA - Canada 34
TR - Turchia 31
FR - Francia 30
ES - Italia 21
MX - Messico 17
PL - Polonia 17
AT - Austria 15
AR - Argentina 14
LT - Lituania 11
CZ - Repubblica Ceca 9
ZA - Sudafrica 9
IE - Irlanda 7
BD - Bangladesh 6
CH - Svizzera 6
CO - Colombia 6
IQ - Iraq 6
NO - Norvegia 6
DK - Danimarca 5
NG - Nigeria 5
UA - Ucraina 5
AU - Australia 4
BG - Bulgaria 4
EC - Ecuador 4
GR - Grecia 4
PT - Portogallo 4
DZ - Algeria 3
EG - Egitto 3
ID - Indonesia 3
MA - Marocco 3
PE - Perù 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
CL - Cile 2
IR - Iran 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 4.111
Città #
Milan 210
Ashburn 202
Singapore 187
Dallas 152
Hong Kong 129
Rome 107
New York 88
Shanghai 72
Beijing 55
Hefei 41
Los Angeles 40
Boardman 36
Turin 36
Verona 33
Munich 32
Tokyo 30
Lawrence 28
Princeton 28
Bologna 27
Florence 25
Pune 21
São Paulo 21
Genoa 20
Helsinki 20
Brooklyn 19
Bari 16
Hanoi 15
Montreal 15
Moscow 15
Catania 13
Denver 12
Palermo 12
Turku 12
Azzano San Paolo 11
Frankfurt am Main 11
Ho Chi Minh City 11
Naples 11
Warsaw 10
Amsterdam 9
Bolzano 9
Phoenix 9
Santa Clara 9
Toronto 9
Chennai 8
Council Bluffs 8
Houston 8
Manchester 8
The Dalles 8
Trieste 8
Vienna 8
Ankara 7
Brescia 7
Bursa 7
Chicago 7
Columbus 7
Dublin 7
Guangzhou 7
Lamezia Terme 7
Modena 7
Nuremberg 7
Padova 7
Paris 7
Porto Alegre 7
Atlanta 6
Bergamo 6
Hayamiya 6
Istanbul 6
Johannesburg 6
London 6
Mexico City 6
Montepulciano 6
Orem 6
Parma 6
Poplar 6
Stockholm 6
Venice 6
Andria 5
Falconara Marittima 5
Mumbai 5
Pavia 5
Prato 5
Rio de Janeiro 5
Treviso 5
Arcore 4
Brasília 4
Cesano Boscone 4
Lappeenranta 4
Melbourne 4
Novara 4
Oslo 4
Passo Fundo 4
Pisa 4
Querétaro 4
Seattle 4
Trento 4
Vicenza 4
Washington 4
's-Hertogenbosch 3
Aarhus 3
Agrigento 3
Totale 2.193
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.627
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 112
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 103
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 84
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 79
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 78
How to Select the Optimal Candidates for Renal Mass Biopsy 77
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 74
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 73
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 73
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 72
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 72
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 71
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 69
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 68
The obesity paradox in metastatic castration-resistant prostate cancer 68
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 67
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 66
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 66
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 66
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 65
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 64
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 63
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 60
A Plea for Economically Sustainable Evidence-based Guidelines 60
Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation 59
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 59
Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery 57
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 55
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 55
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 54
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 52
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 51
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 47
UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer 45
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 42
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 38
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 38
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 37
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 34
RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperative Outcomes 34
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 19
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 16
null 1
Totale 4.170
Categoria #
all - tutte 18.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 8 2 0 0 0 0 0
2021/2022109 0 9 1 18 7 6 14 11 5 9 17 12
2022/2023385 74 60 28 21 21 58 27 41 20 5 18 12
2023/2024751 18 21 31 50 53 133 41 156 12 60 71 105
2024/20251.478 163 64 128 75 87 124 202 164 189 97 74 111
2025/20261.435 243 198 192 422 305 75 0 0 0 0 0 0
Totale 4.170